JPS5536470A - Novel prostaglandin derivative of delta 2*44111deoxyypge series - Google Patents

Novel prostaglandin derivative of delta 2*44111deoxyypge series

Info

Publication number
JPS5536470A
JPS5536470A JP8512479A JP8512479A JPS5536470A JP S5536470 A JPS5536470 A JP S5536470A JP 8512479 A JP8512479 A JP 8512479A JP 8512479 A JP8512479 A JP 8512479A JP S5536470 A JPS5536470 A JP S5536470A
Authority
JP
Japan
Prior art keywords
novel prostaglandin
delta
series
denotes
straight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8512479A
Other languages
English (en)
Inventor
Barutoman Buiruherumu
Betsuku Geruharuto
Reruhi Ururitsuhi
Bitsukeru Maruchin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of JPS5536470A publication Critical patent/JPS5536470A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5428Acyclic unsaturated phosphonium compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/535Organo-phosphoranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
JP8512479A 1978-07-08 1979-07-06 Novel prostaglandin derivative of delta 2*44111deoxyypge series Pending JPS5536470A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782830079 DE2830079A1 (de) 1978-07-08 1978-07-08 Neue prostaglandinderivate der delta 2,4-11-desoxy-pge-reihe

Publications (1)

Publication Number Publication Date
JPS5536470A true JPS5536470A (en) 1980-03-14

Family

ID=6043884

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8512479A Pending JPS5536470A (en) 1978-07-08 1979-07-06 Novel prostaglandin derivative of delta 2*44111deoxyypge series

Country Status (10)

Country Link
US (1) US4258057A (ja)
EP (1) EP0007490B1 (ja)
JP (1) JPS5536470A (ja)
AT (1) ATE720T1 (ja)
AU (1) AU531714B2 (ja)
CA (1) CA1156226A (ja)
DE (2) DE2830079A1 (ja)
ES (1) ES482128A1 (ja)
IL (1) IL57738A (ja)
ZA (1) ZA793388B (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63131366U (ja) * 1987-02-20 1988-08-26
JPH01156956A (ja) * 1987-10-02 1989-06-20 Kei Onishi プロスタグランジン誘導体エステル

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4552898A (en) * 1982-07-14 1985-11-12 Syntex (U.S.A.) Inc. [3.2.0]Bicycloheptanone oxime ethers with valuable therapeutic properties
US7842727B2 (en) * 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US8026280B2 (en) 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US6495719B2 (en) 2001-03-27 2002-12-17 Circagen Pharmaceutical Histone deacetylase inhibitors
US7312247B2 (en) * 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US20030108512A1 (en) * 2001-12-10 2003-06-12 Robert Shorr Modified prostaglandin compounds and analogs thereof, compositions containing the same useful for the treatment of cancer
CA2486303C (en) * 2002-05-22 2013-04-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
CA2506504A1 (en) * 2002-11-20 2004-06-03 Errant Gene Therapeutics, Llc Treatment of lung cells with histone deacetylase inhibitors
WO2006052916A2 (en) * 2004-11-08 2006-05-18 Errant Gene Therapeutics, Inc. Histone deacetylase inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1414383A (en) * 1972-11-14 1975-11-19 Syntex Corp Prostatrienoic acid derivatives and process
US4024174A (en) * 1973-12-25 1977-05-17 Ono Pharmaceutical Company Tranes-delta 2-prostaglandins
US4098815A (en) * 1974-02-15 1978-07-04 Hoechst Aktiengesellschaft Novel analogues of prostanoic acids not occurring in nature
US4165437A (en) * 1976-03-12 1979-08-21 Ono Pharmaceutical Company, Ltd. Δ3 -Prostaglandin analogs
US4061670A (en) * 1976-07-19 1977-12-06 American Cyanamid Company 15-Deoxy-16-hydroxy-16-vinyl and cyclopropyl substituted prostanoic acids and congeners

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63131366U (ja) * 1987-02-20 1988-08-26
JPH01156956A (ja) * 1987-10-02 1989-06-20 Kei Onishi プロスタグランジン誘導体エステル

Also Published As

Publication number Publication date
ES482128A1 (es) 1980-08-16
IL57738A0 (en) 1979-11-30
EP0007490B1 (de) 1982-02-24
US4258057A (en) 1981-03-24
AU4871479A (en) 1980-01-17
EP0007490A3 (en) 1980-05-14
DE2830079A1 (de) 1980-01-17
CA1156226A (en) 1983-11-01
IL57738A (en) 1983-05-15
DE2962192D1 (en) 1982-03-25
EP0007490A2 (de) 1980-02-06
ATE720T1 (de) 1982-03-15
AU531714B2 (en) 1983-09-01
ZA793388B (en) 1980-06-25

Similar Documents

Publication Publication Date Title
JPS5536470A (en) Novel prostaglandin derivative of delta 2*44111deoxyypge series
ES388869A1 (es) Un procedimiento para la preparacion de compuestos de del- ta3-cefalosporina.
ES443912A1 (es) Procedimiento para preparar derivados del acido fenil-aceti-co.
AU559925B2 (en) Carbocyclic prostacyclin alcohol analogs
HUT37935A (en) Process for production of 3-alkoxi-2-n-pirrolidin-n-piridil-n-furil /or n-tienil/-methil-prophil amins
ES460608A1 (es) Procedimiento para la preparacion de nuevos derivados de ci-clopentano.
CS231985B1 (en) Manufacturing process of hydrocarbon solution of alkylsodium compound
GB1445668A (en) Process for obtaining the optical isomers of penicillamine
HUT36814A (en) Process for producing new corbacyylin derivatives and pharmaceutical compositions containing them
DE3269484D1 (en) Process for the preparation of a lactam
DK320181A (da) Fremgangsmaade til fremstilling af cycloalkanothiazolyloxamidsyrederivater
ES8102110A1 (es) Procedimiento para la preparacion de acido 1,2,3-tiadiazol- 5-il-tioglicolico
GB1528224A (en) Manufacture of salts of o,s-dithiophosphoric acids
GR74058B (ja)
JPS5265251A (en) Synthesis of prostaglandin derivatives
ES8303315A1 (es) "procedimiento para la preparacion de 4-metilmercapto-2-acetoxi-butiraldehido".
JPS51115991A (en) Process for producing prostaglandins
DE2964019D1 (en) Process for the preparation of beta-(5-nitro-2-furyl)-acrolein
ES444002A1 (es) Un procedimiento para separar la d-p-hidroxifenilglicina de una mezcla.
JPS51131858A (en) Process for preparing 16-substituted- prostaglandin derivatives
KR830001197A (ko) △2-11-데스옥시-pgf₂또는 pge₂계열의 프로스타글란딘 유도체의 제조방법 및 이의 약물로서의 용도
FR2285384B1 (ja)
GB728968A (en) Process for the preparation of piperazides of the lysergic acid series
JPS53141261A (en) Intermediates for prostaglandins and process for their preparation
JPS5221391A (en) Process for preparing prostaglandin intermediates